Imminence Truly Inevitable, page-15

To add a comment to the above, I have long held a suspicion that the "GSK trials with manual toothbrush not good enough" cursory paragraph in a shareholder update of more than year ago was a smoke-screen designed to quell further public (shareholder) interest in the oral care product application of the company's technology. I have since occasionally inquired of Glyn about where we're at with this, and have got only vague answers. Yet here we are, the company in the last 2 years continuing to press the United States patent office for allowance of their oral care patent application, paying large sums of money to their American patent attorneys to secure the grant of the patent because the company obviously sees some commercial benefit. I have drawn the inference that trials have continued to be conducted in secret (at the demand of the relevant OBJ partner) and we will hear more about this in due course no doubt. All IMHO.